67Commission may issue or refuse to issue VAD substance authorisation

### 67 Commission may issue or refuse to issue VAD substance authorisation > > (1)  If the Commission receives a request under [section 66(1)](#GS66@Gs1@EN) from a person’s PMP, the Commission must, as soon as reasonably practicable – > > > > > > (a) issue to the PMP a VAD substance authorisation in relation to the person; or > > > > > > > (b) if [section 68(1)](#GS68@Gs1@EN) applies, refuse to issue to the PMP a VAD substance authorisation in relation to the person. > > > (2)  A VAD substance authorisation in relation to a person is an instrument in writing, in the approved form, that is signed by the Commission and that – > > > > > > (a) contains the relevant details in relation to a VAD substance authorisation in respect of the person; and > > > > > > > (b) specifies that the person’s PMP is authorised to issue a VAD substance prescription in relation to the person. > > > (3)  For the purposes of [subsection (2)(a)](#GS67@Gs2@Hpa@EN) , the relevant details in relation to a VAD substance authorisation in respect of a person are – > > > > > > (a) the name of the person and the address at which the person is ordinarily resident; and > > > > > > > (b) the name of the person’s PMP at the time when the VAD substance authorisation is issued; and > > > > > > > (c) the details of the VAD substance to which the VAD substance prescription is to relate; and > > > > > > > (d) the maximum amount of the VAD substance, the supply and possession of which is to be authorised by the VAD substance prescription; and > > > > > > > (e) the period for which the person’s PMP is authorised to issue the VAD substance prescription. > > > (4)  A VAD substance authorisation may relate to either of the following: > > > > > > (a) a VAD substance that may be self-administered by the person to whom the VAD substance relates; > > > > > > > (b) a VAD substance that may be administered to the person by the AHP in relation to the person.